Literature DB >> 34610122

We Are all Responsible for Transgender Care.

Ariel Cohen1, Veronica Gomez-Lobo1.   

Abstract

Entities:  

Keywords:  adolescents; gender diverse; gender dysphoria; gender nonbinary; hormone therapy; puberty blockers; transgender

Mesh：

Year:  2022        PMID： 34610122      PMCID： PMC8852158          DOI： 10.1210/clinem/dgab723

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   6.134


× No keyword cloud information.
  6 in total

1.  Pubertal delay as an aid in diagnosis and treatment of a transsexual adolescent.

Authors:  P T Cohen-Kettenis; S H van Goozen
Journal:  Eur Child Adolesc Psychiatry       Date:  1998-12       Impact factor: 4.785

2.  Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline.

Authors:  Wylie C Hembree; Peggy T Cohen-Kettenis; Louis Gooren; Sabine E Hannema; Walter J Meyer; M Hassan Murad; Stephen M Rosenthal; Joshua D Safer; Vin Tangpricha; Guy G T'Sjoen
Journal:  J Clin Endocrinol Metab       Date:  2017-11-01       Impact factor: 5.958

Review 3.  Clinical management of gender dysphoria in children and adolescents: the Dutch approach.

Authors:  Annelou L C de Vries; Peggy T Cohen-Kettenis
Journal:  J Homosex       Date:  2012

4.  Not just a tragic compromise: The positive case for adolescent access to puberty-blocking treatment.

Authors:  Danielle M Wenner; B R George
Journal:  Bioethics       Date:  2021-08-24       Impact factor: 1.898

5.  Access to Care for Transgender and Nonbinary Youth: Ponder This, Innumerable Barriers Exist.

Authors:  David J Inwards-Breland; Baer Karrington; Gina M Sequeira
Journal:  JAMA Pediatr       Date:  2021-11-01       Impact factor: 16.193

6.  Approach to the Patient: Pharmacological Management of Trans and Gender-Diverse Adolescents.

Authors:  Michele A O'Connell; Thomas P Nguyen; Astrid Ahler; S Rachel Skinner; Ken C Pang
Journal:  J Clin Endocrinol Metab       Date:  2022-01-01       Impact factor: 5.958
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.